EAM
SRPT icon

Eventide Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-214,374
Closed -$13.7M 253
2025
Q1
$13.7M Sell
214,374
-58,580
-21% -$3.74M 0.27% 108
2024
Q4
$33.2M Hold
272,954
0.6% 52
2024
Q3
$34.1M Buy
272,954
+44,425
+19% +$5.55M 0.59% 60
2024
Q2
$36.1M Buy
228,529
+93,063
+69% +$14.7M 0.62% 51
2024
Q1
$17.5M Buy
135,466
+46,247
+52% +$5.99M 0.28% 101
2023
Q4
$8.6M Sell
89,219
-33,424
-27% -$3.22M 0.14% 125
2023
Q3
$14.9M Hold
122,643
0.27% 102
2023
Q2
$14M Sell
122,643
-64,625
-35% -$7.4M 0.24% 106
2023
Q1
$25.8M Buy
+187,268
New +$25.8M 0.47% 70
2021
Q2
Sell
-697,156
Closed -$52M 162
2021
Q1
$52M Sell
697,156
-234,356
-25% -$17.5M 0.77% 48
2020
Q4
$159M Hold
931,512
2.44% 7
2020
Q3
$131M Sell
931,512
-64,488
-6% -$9.06M 2.56% 7
2020
Q2
$160M Hold
996,000
3.47% 2
2020
Q1
$97.4M Hold
996,000
3.16% 2
2019
Q4
$129M Sell
996,000
-223,000
-18% -$28.8M 3.62% 3
2019
Q3
$91.8M Buy
1,219,000
+96,000
+9% +$7.23M 3.03% 4
2019
Q2
$171M Buy
1,123,000
+277,832
+33% +$42.2M 5.19% 2
2019
Q1
$101M Hold
845,168
3.47% 5
2018
Q4
$92.2M Buy
845,168
+225,168
+36% +$24.6M 4.08% 2
2018
Q3
$100M Buy
620,000
+245,000
+65% +$39.6M 3.68% 2
2018
Q2
$49.6M Buy
375,000
+149,000
+66% +$19.7M 2.06% 7
2018
Q1
$16.7M Buy
226,000
+65,000
+40% +$4.82M 0.78% 47
2017
Q4
$8.96M Hold
161,000
0.47% 62
2017
Q3
$7.3M Buy
+161,000
New +$7.3M 0.41% 66
2016
Q2
Sell
-332,300
Closed -$6.49M 135
2016
Q1
$6.49M Hold
332,300
0.36% 66
2015
Q4
$12.8M Buy
332,300
+5,900
+2% +$228K 0.64% 51
2015
Q3
$10.5M Buy
326,400
+67,300
+26% +$2.16M 0.61% 51
2015
Q2
$7.88M Hold
259,100
0.43% 61
2015
Q1
$3.44M Hold
259,100
0.26% 78
2014
Q4
$3.75M Hold
259,100
0.41% 66
2014
Q3
$5.47M Hold
259,100
0.76% 54
2014
Q2
$7.72M Hold
259,100
1.05% 46
2014
Q1
$6.23M Buy
259,100
+117,300
+83% +$2.82M 0.97% 48
2013
Q4
$2.89M Buy
+141,800
New +$2.89M 0.89% 49